EE03953B1 - 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks - Google Patents
2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviksInfo
- Publication number
- EE03953B1 EE03953B1 EEP199900007A EE9900007A EE03953B1 EE 03953 B1 EE03953 B1 EE 03953B1 EE P199900007 A EEP199900007 A EE P199900007A EE 9900007 A EE9900007 A EE 9900007A EE 03953 B1 EE03953 B1 EE 03953B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- alzheimer
- phenyl
- treatment
- benzisoselenazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22551296 | 1996-08-27 | ||
| PCT/DE1997/000701 WO1998008511A1 (de) | 1996-08-27 | 1997-04-07 | Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900007A EE9900007A (et) | 1999-06-15 |
| EE03953B1 true EE03953B1 (et) | 2003-02-17 |
Family
ID=16830487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900007A EE03953B1 (et) | 1996-08-27 | 1997-04-07 | 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5948800A (pl) |
| EP (1) | EP0826370B1 (pl) |
| KR (1) | KR20000035859A (pl) |
| CN (1) | CN1112922C (pl) |
| AT (1) | ATE219361T1 (pl) |
| AU (2) | AU3866997A (pl) |
| BR (1) | BR9711259A (pl) |
| CA (1) | CA2213794C (pl) |
| CZ (1) | CZ295364B6 (pl) |
| DE (2) | DE59707550D1 (pl) |
| DK (1) | DK0826370T3 (pl) |
| EE (1) | EE03953B1 (pl) |
| ES (1) | ES2177849T3 (pl) |
| FI (1) | FI119622B (pl) |
| HK (1) | HK1020317A1 (pl) |
| HU (1) | HU225264B1 (pl) |
| IL (1) | IL127113A (pl) |
| LT (1) | LT4602B (pl) |
| LV (1) | LV12251B (pl) |
| NO (1) | NO312812B1 (pl) |
| NZ (1) | NZ332292A (pl) |
| PL (1) | PL188481B1 (pl) |
| PT (1) | PT826370E (pl) |
| SI (1) | SI9720060B (pl) |
| TR (1) | TR199700858A2 (pl) |
| TW (1) | TW501925B (pl) |
| UA (1) | UA59367C2 (pl) |
| WO (2) | WO1998008511A1 (pl) |
| ZA (1) | ZA977644B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0729756T3 (da) * | 1993-10-27 | 2000-06-05 | Daiichi Seiyaku Co | Granulært farmaceutisk præparat |
| JP2000016935A (ja) * | 1998-07-01 | 2000-01-18 | Dai Ichi Seiyaku Co Ltd | シクロオキシゲナーゼ阻害剤 |
| CA2368484A1 (en) | 1999-03-31 | 2000-10-05 | Daiichi Pharmaceutical Co., Ltd. | Substrates for thioredoxin reductase |
| WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
| WO2003010143A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co., Ltd. | Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| WO2003010153A1 (en) | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| GB201102248D0 (en) | 2011-02-09 | 2011-03-23 | Isis Innovation | Treatment of bipolar disorder |
| CN103965188A (zh) * | 2013-01-29 | 2014-08-06 | 中山大学 | 含硒多奈哌齐类似物 |
| EP2950102A1 (en) | 2014-05-30 | 2015-12-02 | Biocross, S.L. | Method for the diagnosis of alzheimer s disease and mild cognitive impairment |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| EP3067699A1 (en) | 2015-03-11 | 2016-09-14 | Neuron Bio, S.A. | Method for diagnosing alzheimer's disease |
| PL237739B1 (pl) | 2018-06-06 | 2021-05-17 | Univ Gdanski | Genisteina do zastosowania do leczenia choroby Alzheimera |
| CN113116888B (zh) * | 2021-04-19 | 2022-08-26 | 上海兴糖生物技术有限公司 | 依布硒啉的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616923A1 (de) * | 1986-05-20 | 1987-11-26 | Nattermann A & Cie | Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on |
| DE3638124C2 (de) * | 1986-11-08 | 1996-09-05 | Nattermann A & Cie | Neue pharmazeutische Verwendung von Ebselen |
| JPH01131113A (ja) * | 1987-08-27 | 1989-05-24 | Dai Ichi Seiyaku Co Ltd | 脳障害治療剤 |
| JPH0238591A (ja) | 1988-07-27 | 1990-02-07 | Fujikura Ltd | 高純度銅の製造方法 |
| US5385726A (en) * | 1990-08-06 | 1995-01-31 | Rhone-Poulenc Rorer Gmbh | Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one |
| DE4024885C2 (de) * | 1990-08-06 | 2002-07-18 | Nattermann A & Cie | Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on |
| FR2669633B1 (fr) * | 1990-11-23 | 1993-01-22 | Adir | Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JPH07233056A (ja) * | 1993-09-03 | 1995-09-05 | Dai Ichi Seiyaku Co Ltd | リポキシゲナーゼ阻害剤 |
-
1997
- 1997-03-17 AT AT97104503T patent/ATE219361T1/de not_active IP Right Cessation
- 1997-03-17 ES ES97104503T patent/ES2177849T3/es not_active Expired - Lifetime
- 1997-03-17 DK DK97104503T patent/DK0826370T3/da active
- 1997-03-17 EP EP97104503A patent/EP0826370B1/de not_active Expired - Lifetime
- 1997-03-17 PT PT97104503T patent/PT826370E/pt unknown
- 1997-03-17 DE DE59707550T patent/DE59707550D1/de not_active Expired - Fee Related
- 1997-04-07 WO PCT/DE1997/000701 patent/WO1998008511A1/de active IP Right Grant
- 1997-04-07 NZ NZ332292A patent/NZ332292A/en unknown
- 1997-04-07 SI SI9720060A patent/SI9720060B/sl not_active IP Right Cessation
- 1997-04-07 CN CN97195890A patent/CN1112922C/zh not_active Expired - Fee Related
- 1997-04-07 BR BR9711259A patent/BR9711259A/pt not_active Application Discontinuation
- 1997-04-07 IL IL12711397A patent/IL127113A/xx not_active IP Right Cessation
- 1997-04-07 CZ CZ1999317A patent/CZ295364B6/cs not_active IP Right Cessation
- 1997-04-07 HU HU9903213A patent/HU225264B1/hu not_active IP Right Cessation
- 1997-04-07 EE EEP199900007A patent/EE03953B1/xx not_active IP Right Cessation
- 1997-07-04 UA UA99010526A patent/UA59367C2/uk unknown
- 1997-08-04 DE DE19733690A patent/DE19733690A1/de not_active Withdrawn
- 1997-08-04 US US08/905,530 patent/US5948800A/en not_active Expired - Lifetime
- 1997-08-20 AU AU38669/97A patent/AU3866997A/en not_active Abandoned
- 1997-08-20 KR KR1019997001554A patent/KR20000035859A/ko not_active Application Discontinuation
- 1997-08-20 WO PCT/JP1997/002883 patent/WO1998008831A1/ja not_active Application Discontinuation
- 1997-08-21 TW TW086112018A patent/TW501925B/zh not_active IP Right Cessation
- 1997-08-25 CA CA002213794A patent/CA2213794C/en not_active Expired - Fee Related
- 1997-08-26 PL PL97321796A patent/PL188481B1/pl not_active IP Right Cessation
- 1997-08-26 NO NO19973912A patent/NO312812B1/no not_active IP Right Cessation
- 1997-08-26 AU AU35298/97A patent/AU725534B2/en not_active Ceased
- 1997-08-26 ZA ZA977644A patent/ZA977644B/xx unknown
- 1997-08-27 TR TR97/00858A patent/TR199700858A2/xx unknown
-
1998
- 1998-10-22 LV LVP-98-231A patent/LV12251B/lv unknown
- 1998-12-11 FI FI982689A patent/FI119622B/fi not_active IP Right Cessation
-
1999
- 1999-02-23 LT LT99-016A patent/LT4602B/lt not_active IP Right Cessation
- 1999-11-29 HK HK99105534A patent/HK1020317A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK549189A (da) | Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge | |
| LV12438A (en) | Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof | |
| HUP0103654A2 (hu) | Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására | |
| EE9900007A (et) | 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks | |
| FI950909A (fi) | Rasvahappojohdannaisia | |
| HUP0002742A2 (hu) | Mirtazapint és antipszichotikus szert tartalmazó új gyógyászati kombinációk pszichózisos rendellenességek kezelésére vagy megelőzésére | |
| ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| CA2078700A1 (en) | Imidazolylmethyl-pyridines | |
| ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
| BR9909868A (pt) | Ascorbato de paroxetina | |
| ZA961897B (en) | 6,7-substituted-2-aminotetralines and use thereof | |
| SE8802323L (sv) | 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma | |
| RS49595B (sr) | Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti | |
| AU2002318888A1 (en) | Metal Chelators for use in the treatment of Alzheimer's Disease | |
| NO930083D0 (no) | Sammensetning for behandling av alzheimers sykdom og fremgangsmaate for fremstilling | |
| AU2002301084A1 (en) | Identification of agents for use in the treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20040407 |